Christophe Pison

Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

Tim Harrison, Pascal Chanez, Francesco Menzella et al. · The Lancet Respiratory Medicine · 2020 · 175 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +15

Management and long-term outcomes of sarcoidosis-associated pulmonary hypertension

Athénaïs Boucly, Vincent Cottin, Hilario Nunès et al. · European Respiratory Journal · 2017 · 151 citations · Full text

Medicine, Cardiology, Hemodynamic Management +13

Masitinib, a c‐kit/PDGF receptor tyrosine kinase inhibitor, improves disease control in severe corticosteroid‐dependent asthmatics

Marc Humbert, F. de Blay, Gilles Garcia et al. · Allergy · 2009 · 136 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Pulmonary Arterial Hypertension Associated With Systemic Lupus Erythematosus

É. Hachulla, Xavier Jaïs, G. Cinquetti et al. · CHEST Journal · 2017 · 98 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +10

Relationships of allergic sensitization, total immunoglobulin E and blood eosinophils to asthma severity in children of the EGEA Study

Valérie Siroux, Marie‐Pierre Oryszczyn, E. Paty et al. · Clinical & Experimental Allergy · 2003 · 91 citations

Life Sciences, Immunology, Pediatrics +16